Future directions in the field of endometrial cancer research: The need to investigate the tumor microenvironment

European Journal of Gynaecological Oncology

Volumn 31, Issue 2, 2010, Pages 139-144

  Felix, A S ^a,b   Weissfeld, J ^a,b   Edwards, R ^c   Linkov, F ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Endometrial carcinoma; Microenvironment; Tumor markers

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; ESTROGEN RECEPTOR; SCATTER FACTOR RECEPTOR; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN A;

CANCER INVASION; CANCER RESEARCH; ENDOMETRIUM CANCER; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; INFLAMMATORY CELL; METASTASIS; MICROENVIRONMENT; PROTEIN EXPRESSION; REVIEW;

ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; RESEARCH; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 77952527830     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. West R.B., van de Rijn M.: "Experimental approaches to the study of cancer-stroma interactions: recent findings suggest a pivotal role for stroma in carcinogenesis". Lab. Invest., 2007, 87, 967.
2. Anton K., Glod J.: "Targeting the tumor stroma in cancer therapy". Curr. Pharm. Biotechnol., 2009, 10, 185.
3. NCI. EGRP Hosts Workshop on Understudied Rare Cancers, [cited 2009 July 2, 2009]; Available from: http://epi.grants.cancer.gov/Conference2/appendices. html#b
4. Sohaib S.A., Houghton S.L., Meroni R., Rockall A.G., Blake P., Reznek R.H.: "Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis". Clin. Radiol., 2007, 62, 28.
5. Witkiewicz A.K., Casimiro M.C., Dasgupta A., Mercier I., Wang C., Bonuccelli G. et al.: "Towards a new 'stromal-based' classification system for human breast cancer prognosis and therapy". Cell Cycle, 2009, 8, 1654.
6. Taylor R.A., Risbridger G.P.: "Prostatic tumor stroma: a key player in cancer progression". Curr. Cancer Drug. Targets, 2008, 8, 490.
7. Wysoczynski M., Ratajczak M.Z.: "Lung cancer secreted microvesicles: Underappreciated modulators of microenvironment in expanding tumors". Int. J. Cancer, 2009 Apr 6.
8. CRISP. Computer Retrieval of Information of Scientific Papers 2009 [cited 2009 July 6, 2009]; Available from: http://crisp.cit.nih.gov/crisp/crisp-query. generate-screen
9. Itano N., Zhuo L., Kimata K.: "Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression". Cancer Sci., 2008, 99, 1720.
10. Bhowmick N.A., Moses H.L.: "Tumor-stroma interactions". Curr. Opin. Genet. Dev., 2005, 15, 97.
11. Arnold J. T., Lessey B.A., Seppala M., Kaufman D.G.: "Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells". Cancer Res., 2002, 62, 79.
12. Tlsty T.D., Coussens L.M.: "Tumor stroma and regulation of cancer development". Annu. Rev. Pathol., 2006, 1, 119.
13. Tlsty T.D., Hein P.W.: "Know thy neighbor: stromal cells can contribute oncogenic signals". Curr. Opin. Genet. Dev., 2001, 11, 54.
14. Tlsty T.D.: "Stromal cells can contribute oncogenic signals". Semin. Cancer Biol., 2001, 11, 97.
15. Di Renzo M.F., Olivero M., Katsaros D., Crepaldi T., Gaglia P., Zola P. et al.: "Overexpression of the Met/HGF receptor in ovarian cancer". Int. J. Cancer, 1994, 58, 658.
16. Natali P.G., Prat M., Nicotra M.R., Bigotti A., Olivero M., Comoglio P.M. et al.: "Overexpression of the met/HGF receptor in renal cell carcinomas". Int. J. Cancer, 1996, 69, 212. (Pubitemid 26233301)
17. Olivero M., Rizzo M., Madeddu R., Casadio C., Pennacchietti S., Nicotra M.R. et al.: "Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas". Br. J. Cancer, 1996, 74, 1862.
18. Kiehne K., Herzig K.H., Folsch U.R.: "c-met expression in pancreatic cancer and effects of hepatocyte growth factor on pancreatic cancer cell growth". Pancreas., 1997, 15, 35. (Pubitemid 27527357)
19. Humphrey P.A., Zhu X., Zarnegar R., Swanson P.E., Ratliff T.L., Vollmer R.T. et al.: "Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma". Am. J. Pathol., 1995, 147, 386.
20. Wagatsuma S., Konno R., Sato S., Yajima A.: "Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma". Cancer, 1998, 82, 520.
21. De Wever O., Mareel M.: "Role of tissue stroma in cancer cell invasion". J. Pathol., 2003, 200, 429. (Pubitemid 36818244)
22. Coussens L.M., Werb Z.: "Inflammation and cancer". Nature, 2002, 420, 860.
23. Ben-Baruch A.: "Organ selectivity in metastasis: regulation by chemokines and their receptors". Clin. Exp. Metastasis., 2008, 25, 345.
24. Balkwill F.: "Cancer and the chemokine network". Nat. Rev. Cancer, 2004, 4, 540.
25. Gelmini S., Mangoni M., Castiglione F., Beltrami C., Pieralli A., Andersson K.L. et al.: "The CXCR4/CXCL12 axis in endometrial cancer". Clin. Exp. Metastasis., 2009, 26, 261.
26. Mizokami Y., Kajiyama H., Shibata K., Ino K., Kikkawa F., Mizutani S.: "Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma". Int. J. Cancer, 2004, 110, 652.
27. Sanseverino F., Santopietro R., Torricelli M., D'Andrilli G., Russo G., Cevenini G. et al.: "pRb2/p130 and VEGF expression in endometrial carcinoma in relation to angiogenesis and histopathologic tumor grade". Cancer Biol. Ther., 2006, 5, 84. (Pubitemid 43234983)
28. Jung Y.D., Ahmad S.A., Liu W., Reinmuth N., Parikh A., Stoeltzing O. et al.: "The role of the microenvironment and intercellular cross-talk in tumor angiogenesis". Semin. Cancer Biol., 2002, 12, 105.
29. th ed. New York: Oxford University Press, 2005.
30. Kamat A.A., Merritt W.M., Coffey D., Lin Y.G., Patel P.R., Broaddus R. et al.: "Clinical and biological significance of vascular endothelial growth factor in endometrial cancer". Clin. Cancer Res., 2007, 13, 7487.
31. Hirai M., Nakagawara A., Oosaki T., Hayashi Y., Hirono M., Yoshihara T.: "Expression of vascular endothelial growth factors (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in postmenopausal uterine endometrial carcinoma". Gynecol. Oncol., 2001, 80, 181.
32. Stefansson I.M., Salvesen H.B., Akslen L.A.: "Vascular proliferation is important for clinical progress of endometrial cancer". Cancer Res., 2006, 66, 3303.
33. Hecht J.L., Mutter G.L.: "Molecular and pathologic aspects of endometrial carcinogenesis". J. Clin. Oncol., 2006, 24, 4783.
34. Cooke P.S., Buchanan D.L., Young P., Setiawan T., Brody J., Korach K.S et al.: "Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium". Proc. Natl Acad Sci U.S.A., 1997, 94, 6535.
35. Matsumoto M., Yamaguchi Y., Seino Y., Hatakeyama A., Takei H., Niikura H. et al.: "Estrogen signaling ability in human endometrial cancer through the cancer-stromal interaction". Endocr. Relat. Cancer, 2008, 15, 451. (Pubitemid 351880834)
36. Zhao D., Li X.P., Gao M., Zhao C., Wang J.L., Wei L.H.: "Stromal cell-derived factor 1alpha stimulates human endometrial carcinoma cell growth through the activation of both extracellular signal-regulated kinase 1/2 and Akt". Gynecol. Oncol., 2006, 103, 932.
37. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H. et al.: "Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase". Science, 1995, 270, 1491.
38. Choi D.S., Kim H.J., Yoon J.H., Yoo S.C., Jo H., Lee S.Y. et al.: "Endometrial cancer invasion depends on cancer-derived tumor necrosis factor-alpha and stromal derived hepatocyte growth factor". Int. J. Cancer, 2008.
39. Campbell R.A., Bhat-Nakshatri P., Patel N.M., Constantinidou D., Ali S., Nakshatri H.: "Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance". J. Biol. Chem., 2001, 276, 9817.
40. Leong H., Riby J.E., Firestone G.L., Bjeldanes L.F.: "Potent ligand-independent estrogen receptor activation by 3,3'-diindolyl-methane is mediated by cross talk between the protein kinase A and mitogen-activated protein kinase signaling pathways". Mol. Endocrinol., 2004, 18, 291.
41. Segawa T., Shozu M., Murakami K., Kasai T, Shinohara K., Nomura K. et al.: "Aromatase expression in stromal cells of endometrioid endometrial cancer correlates with poor survival". Clin. Cancer Res., 2005, 11, 2188.
42. Cregger M., Berger A.J., Rimm D.L.: "Immunohistochemistry and quantitative analysis of protein expression". Arch. Pathol. Lab. Med., 2006, 130, 1026. (Pubitemid 44061434)
43. Yurkovetsky Z., Ta'asan S., Skates S., Rand A., Lomakin A., Linkov F. et al.: "Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin". Gynecol. Oncol., 2007, 107, 58.
44. Salvesen H.B., Carter S.L., Mannelqvist M., Dutt A., Getz G., Stefansson I.M. et al.: "Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation". Proc. Natl. Acad. Sci USA., 2009, 106, 4834.